Literature DB >> 18256805

[Prevention of thromboembolism in German intensive care units : Results of a nationwide survey].

P Hilbert1, P Teumer, R Stuttmann.   

Abstract

BACKGROUND: Intensive care unit (ICU) patients have a high risk of developing venous thromboembolism (VTE) and prophylaxis is recommended. Venous thromboembolism confers considerable morbidity and mortality in hospitalized patients, although few studies have focused on critically ill patients. METHOD AND
OBJECTIVE: A systematic prospective mailed self-administered survey of 645 German ICU directors was performed, representing 652 ICUs throughout the country. The objective of this study was to understand current approaches to the prevention of VTE among patients in ICUs.
RESULTS: Of the 652 ICUs approached, 470 (72.3%) participated. Thromboembolism prophylaxis was prescribed in 98% of the ICUs. For mechanical prophylaxis graded elastic stockings were used in 93% and pneumatic compression devices in 24%. For pharmacologic prophylaxis low molecular weight heparin was the predominant prophylactic strategy in 88%, whereas unfractionated heparin was used less often in 45%.
CONCLUSION: The prescribed prophylaxis for thromboembolism in 98% of the German ICUs is surprisingly high compared to that given in the literature. A combination of mechanical and pharmacologic prophylaxis is the predominant prophylactic strategy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256805     DOI: 10.1007/s00101-008-1309-y

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  16 in total

1.  Thromboprophylaxis for intensive care patients in Australia and New Zealand: a brief survey report.

Authors:  D James Cooper; Nicole Bishop; John Cade; Simon Finfer; Alex Gallus; John Myburgh
Journal:  J Crit Care       Date:  2005-12       Impact factor: 3.425

2.  Variability in the use of thromboprophylaxis and outcomes in critically ill medical patients.

Authors:  Krista L Lentine; Kara E Flavin; Michael K Gould
Journal:  Am J Med       Date:  2005-12       Impact factor: 4.965

Review 3.  Mechanical thromboprophylaxis in critically ill patients: a systematic review and meta-analysis.

Authors:  Anthony Limpus; Wendy Chaboyer; Ellen McDonald; Lukman Thalib
Journal:  Am J Crit Care       Date:  2006-07       Impact factor: 2.228

4.  [Expert opinion aspects of thrombosis prophylaxis].

Authors:  K Ulsenheimer
Journal:  Chirurg       Date:  2007-02       Impact factor: 0.955

5.  A survey of thromboprophylaxis management in patients with major trauma.

Authors:  Davide Imberti; Walter Ageno
Journal:  Pathophysiol Haemost Thromb       Date:  2005

Review 6.  [Thrombosis prophylaxis with heparins in intensive care patients].

Authors:  A Greinacher; D Janssen
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2005-03       Impact factor: 0.698

7.  [Customary use of compression stockings for prevention of thrombosis in medical intensive care units in Germany].

Authors:  W Müllges; E Steinke; G Moldenhauer; N Berens
Journal:  Dtsch Med Wochenschr       Date:  2001-08-03       Impact factor: 0.628

8.  The incidence of deep venous thrombosis in ICU patients.

Authors:  P E Marik; L Andrews; B Maini
Journal:  Chest       Date:  1997-03       Impact factor: 9.410

Review 9.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  William H Geerts; Graham F Pineo; John A Heit; David Bergqvist; Michael R Lassen; Clifford W Colwell; Joel G Ray
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

10.  Venous thromboembolism deserves your attention.

Authors:  C M Samama
Journal:  Crit Care       Date:  2001-11-03       Impact factor: 9.097

View more
  6 in total

1.  [Recommendations for the administration of conventional and new antithrombotic agents from the perspective of anesthesiology].

Authors:  W Gogarten; K Hoffmann; H Van Aken
Journal:  Unfallchirurg       Date:  2010-11       Impact factor: 1.000

2.  Coagulation Day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care.

Authors:  E Schaden; P G Metnitz; G Pfanner; S Heil; T Pernerstorfer; P Perger; H Schoechl; D Fries; M Guetl; S Kozek-Langenecker
Journal:  Intensive Care Med       Date:  2012-03-24       Impact factor: 17.440

Review 3.  [Heparin-induced thrombocytopenia type II (HIT II) : A medical-economic view].

Authors:  R Riedel; A Schmieder; A Koster; S Kim; G Baumgarten; J C Schewe
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-12-22       Impact factor: 0.840

4.  Bioactivity of enoxaparin in critically ill patients with normal renal function.

Authors:  Ghazaleh Gouya; Stefan Palkovits; Stylianos Kapiotis; Christian Madl; Gottfried Locker; Alexander Stella; Michael Wolzt; Gottfried Heinz
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

Review 5.  [Heparin resistance and antithrombin deficiency].

Authors:  Norbert Maurin
Journal:  Med Klin (Munich)       Date:  2009-06-16

Review 6.  Heparin-induced thrombocytopenia in the ICU: an overview.

Authors:  Yasser Sakr
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.